Geatti O, Shapiro B, Orsolon P G, Mirolo R, Di Donna A
Istituto di Medicina Nucleare, Ospedale Civile, Udine, Italy.
Clin Nucl Med. 1994 Aug;19(8):678-82. doi: 10.1097/00003072-199408000-00006.
Uptake of I-131 in the pericardial area is described in an asymptomatic patient who underwent total body scan for recurrent papillary thyroid cancer. Ultrasonography demonstrated a small pericardial effusion that persisted after I-thyroxine therapy was reinstituted. Two I-131 therapeutic doses were given, and follow-up total body scans were performed during the next 6 years. Although tracer accumulation in the neck was eliminated and the serum thyroglobulin level was not elevated, I-131 uptake persisted in pericardial effusion. Despite diligent study, no neoplastic, infectious, or autoimmune etiology could be demonstrated, and we thus classified it as idiopathic pericardial effusion. This phenomenon should be considered when interpreting I-131 scans that show I-131 uptake in the region of the heart.
在一名因复发性乳头状甲状腺癌接受全身扫描的无症状患者中,描述了I-131在心包区域的摄取情况。超声检查显示有少量心包积液,在重新开始服用左旋甲状腺素治疗后积液持续存在。给予了两次I-131治疗剂量,并在接下来的6年中进行了随访全身扫描。尽管颈部的示踪剂积聚已消除且血清甲状腺球蛋白水平未升高,但心包积液中仍持续存在I-131摄取。尽管进行了深入研究,但未发现肿瘤、感染或自身免疫病因,因此我们将其归类为特发性心包积液。在解读显示心脏区域有I-131摄取的I-131扫描时,应考虑到这种现象。